Medipal HoldingsMEDIPAL HOLDINGS CORPORATION7459東証プライム卸売業FY ending Mar 2026, consolidated, J-GAAP
Out of every ¥100 of sales, about ¥1 is left as operating profit. Revenue changed +4.0% from the prior year, operating profit -4.4%.
Net margin × asset turnover = ROA; ROA × financial leverage = ROE
Denominators: average assets and average equity. Derived from reported values; ROE is shown only for positive profit and equity.
| Period | Net margin | Asset turnover | ROA | Financial leverage | ROE |
|---|---|---|---|---|---|
| 2022 | 0.9% | 1.93× | 1.7% | 3.54× | 6.1% |
| 2023 | 1.2% | 1.97× | 2.3% | 3.43× | 7.8% |
| 2024 | 1.2% | 2.03× | 2.4% | 3.33× | 7.9% |
| 2025 | 1.1% | 2.03× | 2.2% | 3.28× | 7.3% |
| 2026 | 1.1% | 2.04× | 2.3% | 3.27× | 7.4% |
Financial leverage can raise ROE; a higher value alone does not describe a company's overall condition.
Annual trends in tangible-asset ratios and goodwill balance.
Ratios are derived from reported values. Goodwill is shown only when separately reported; it is not inferred from combined intangible assets. Definition
Track R&D investment and how long operating capital remains tied up before sales turn into cash.
R&D is shown only for years with machine-readable disclosure. Days are estimates using year-end receivables, inventory and payables divided by annual revenue or cost of sales; financial companies are excluded.
| Item | FY ending Mar 2022 | FY ending Mar 2023 | FY ending Mar 2024 | FY ending Mar 2025 | FY ending Mar 2026 |
|---|---|---|---|---|---|
| Revenue | 3,290,921 | 3,360,008 | 3,558,732 | 3,671,328 | 3,817,354 |
| Cost of revenue | 3,073,476 | 3,135,703 | 3,312,077 | 3,415,569 | 3,556,366 |
| Gross profit | 217,445 | 224,304 | 246,654 | 255,758 | 260,987 |
| SG&A | 171,820 | 175,331 | 199,324 | 200,148 | 207,804 |
| Operating income | 45,624 | 48,972 | 47,330 | 55,609 | 53,182 |
| Pretax income | 57,284 | 70,061 | 74,741 | 76,734 | 81,844 |
| Income tax | 18,087 | 21,738 | 22,973 | 25,203 | 28,703 |
| Net income attributable to owners | 29,423 | 38,806 | 41,474 | 40,279 | 42,534 |
| Operating margin | 1.4% | 1.5% | 1.3% | 1.5% | 1.4% |
Year-end figures from filings. Unreported items are omitted. Interest-bearing debt excludes lease liabilities.
Each bar totals 100% of assets; other is the residual.
| Item | FY ending Mar 2022 | FY ending Mar 2023 | FY ending Mar 2024 | FY ending Mar 2025 | FY ending Mar 2026 |
|---|---|---|---|---|---|
| Cash and equivalents | ¥260.4B | ¥193.6B | ¥228.1B | ¥259.3B | ¥286.5B |
| Total assets | ¥1.71T | ¥1.71T | ¥1.8T | ¥1.82T | ¥1.92T |
| Net assets | ¥649.1B | ¥688.1B | ¥736.6B | ¥757.9B | ¥795.4B |
| Share capital | ¥22.4B | ¥22.4B | ¥22.4B | ¥22.4B | ¥22.4B |
| Property, plant and equipment | ¥264.4B | ¥268.4B | ¥271B | ¥268.6B | ¥261.8B |
| Intangible assets excluding goodwill | ¥9.97B | ¥40B | ¥39B | ¥39.9B | ¥37.5B |
| Goodwill | ¥604M | ¥11.9B | ¥11.6B | ¥13.2B | ¥12.3B |
| Investment securities | ¥190.8B | ¥192.6B | ¥210.9B | ¥199.1B | ¥212.5B |
| Current assets | ¥1.21T | ¥1.18T | ¥1.24T | ¥1.28T | ¥1.37T |
| Current liabilities | ¥1.01T | ¥971.5B | ¥1.01T | ¥1.01T | ¥1.07T |
| Trade payables | ¥908B | ¥891B | ¥924.3B | ¥932.5B | ¥984.5B |
| Total liabilities | ¥1.06T | ¥1.02T | ¥1.06T | ¥1.07T | ¥1.13T |
| Non-controlling interests | ¥118.8B | ¥126.7B | ¥136.3B | ¥138.4B | ¥143.2B |
| Equity attributable to owners of parent | ¥483.3B | ¥512.4B | ¥540.3B | ¥563.3B | ¥584.1B |
| Retained earnings | ¥385.6B | ¥414.7B | ¥439.3B | ¥463.1B | ¥485B |
| Treasury stock | -¥58.6B | -¥26.3B | -¥21.3B | -¥22.2B | -¥23.4B |
EDINET (FSA Japan)
有価証券報告書－第117期(2025/04/01－2026/03/31)
EDINET (FSA Japan)
有価証券報告書－第116期(2024/04/01－2025/03/31)
EDINET (FSA Japan)
有価証券報告書－第115期(2023/04/01－2024/03/31)
EDINET (FSA Japan)
有価証券報告書－第114期(2022/04/01－2023/03/31)
EDINET (FSA Japan)
有価証券報告書－第113期(令和3年4月1日－令和4年3月31日)
EDINET (FSA Japan)
有価証券報告書－第112期(令和2年4月1日－令和3年3月31日)
Extracted from XBRL: 52 / Derived from other figures: 1
Spotted an error? Report it (corrections keep the original record)
Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.